Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AvantGen
San Diego, California, United Statesepo.org ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
AvantGen has demonstrated the ability to rapidly generate high-affinity antibodies using its proprietary platforms. Its technology has contributed to investigational therapies now in Phase I trials through partnerships—such as a novel CD19-targeting CAR-T construct with Kite/Gilead—and licensed anti-SARS-CoV‑2 antibodies showing potent neutralization in vitro and animal models. The company’s main business model centers on discovery services, licensing, and collaborations rather than developing an internal therapeutic pipeline through late-stage clinical trials.
- Therapeutic areas
- OtherOncologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)scFvs (single-chain variable fragments)NK cell engagersT cell engagers
- Industry
- Drug Discovery Services
02
Partnerships
Kite Pharma / Gilead SciencesUniversity of PennsylvaniaTanabe Research Laboratories U.S.A.IGM Biosciencesmultiple pharmaceutical/biotech/government entities including NIH grants/contracts.
Beyond the preview
Go deeper on AvantGen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AvantGen.